[HTML][HTML] Reprogramming of human peripheral blood mononuclear cells into induced mesenchymal stromal cells using non-integrating vectors
W Chen, C Wang, ZX Yang, F Zhang, W Wen… - Communications …, 2023 - nature.com
Mesenchymal stromal cells (MSCs) have great value in cell therapies. The MSC therapies
have many challenges due to its inconsistent potency and limited quantity. Here, we report a …
have many challenges due to its inconsistent potency and limited quantity. Here, we report a …
Reprogramming of human peripheral blood mononuclear cells into induced mesenchymal stromal cells using non-integrating vectors.
W Chen, C Wang, ZX Yang, F Zhang… - Communications …, 2023 - search.ebscohost.com
Mesenchymal stromal cells (MSCs) have great value in cell therapies. The MSC therapies
have many challenges due to its inconsistent potency and limited quantity. Here, we report a …
have many challenges due to its inconsistent potency and limited quantity. Here, we report a …
Reprogramming of human peripheral blood mononuclear cells into induced mesenchymal stromal cells using non-integrating vectors
W Chen, C Wang, ZX Yang, F Zhang… - Communications …, 2023 - search.proquest.com
Mesenchymal stromal cells (MSCs) have great value in cell therapies. The MSC therapies
have many challenges due to its inconsistent potency and limited quantity. Here, we report a …
have many challenges due to its inconsistent potency and limited quantity. Here, we report a …
[HTML][HTML] Reprogramming of human peripheral blood mononuclear cells into induced mesenchymal stromal cells using non-integrating vectors
W Chen, C Wang, ZX Yang, F Zhang… - Communications …, 2023 - ncbi.nlm.nih.gov
Mesenchymal stromal cells (MSCs) have great value in cell therapies. The MSC therapies
have many challenges due to its inconsistent potency and limited quantity. Here, we report a …
have many challenges due to its inconsistent potency and limited quantity. Here, we report a …
Reprogramming of human peripheral blood mononuclear cells into induced mesenchymal stromal cells using non-integrating vectors.
W Chen, C Wang, ZX Yang, F Zhang, W Wen… - Communications …, 2023 - europepmc.org
Mesenchymal stromal cells (MSCs) have great value in cell therapies. The MSC therapies
have many challenges due to its inconsistent potency and limited quantity. Here, we report a …
have many challenges due to its inconsistent potency and limited quantity. Here, we report a …
[引用][C] Reprogramming of human peripheral blood mononuclear cells into induced mesenchymal stromal cells using non-integrating vectors
W Chen, C Wang, ZX Yang… - …, 2023 - lomalinda.elsevierpure.com
Reprogramming of human peripheral blood mononuclear cells into induced mesenchymal
stromal cells using non-integrating vectors — Faculty Research (Pure) - Loma Linda University …
stromal cells using non-integrating vectors — Faculty Research (Pure) - Loma Linda University …
Reprogramming of human peripheral blood mononuclear cells into induced mesenchymal stromal cells using non-integrating vectors
W Chen, C Wang, ZX Yang, F Zhang… - Communications …, 2023 - pubmed.ncbi.nlm.nih.gov
Mesenchymal stromal cells (MSCs) have great value in cell therapies. The MSC therapies
have many challenges due to its inconsistent potency and limited quantity. Here, we report a …
have many challenges due to its inconsistent potency and limited quantity. Here, we report a …
Reprogramming of human peripheral blood mononuclear cells into induced mesenchymal stromal cells using non-integrating vectors.
W Chen, C Wang, ZX Yang, F Zhang, W Wen… - Communications …, 2023 - europepmc.org
Mesenchymal stromal cells (MSCs) have great value in cell therapies. The MSC therapies
have many challenges due to its inconsistent potency and limited quantity. Here, we report a …
have many challenges due to its inconsistent potency and limited quantity. Here, we report a …